NINLARO 2.3 MG Israel - English - Ministry of Health

ninlaro 2.3 mg

takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 2.3 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.

NINLARO 3 MG Israel - English - Ministry of Health

ninlaro 3 mg

takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 3 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.

NINLARO 4 MG Israel - English - Ministry of Health

ninlaro 4 mg

takeda israel ltd - ixazomib as citrate - capsules - ixazomib as citrate 4 mg - ixazomib - ninlaro is indicated, in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.

ALUNBRIG 30 MG Israel - English - Ministry of Health

alunbrig 30 mg

takeda israel ltd - brigatinib - film coated tablets - brigatinib 30 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)

ALUNBRIG 90 MG Israel - English - Ministry of Health

alunbrig 90 mg

takeda israel ltd - brigatinib - film coated tablets - brigatinib 90 mg - brigatinib - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc)

DEXILANT 30 MG Israel - English - Ministry of Health

dexilant 30 mg

takeda israel ltd - dexlansoprazole - modified release capsules - dexlansoprazole 30 mg - dexlansoprazole - dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:• maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn• short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (gord).

DEXILANT 60 MG Israel - English - Ministry of Health

dexilant 60 mg

takeda israel ltd - dexlansoprazole - modified release capsules - dexlansoprazole 60 mg - dexlansoprazole - dexilant 60 is indicated in adults and in adolescents aged 12 to 17 years for the following:• treatment of erosive reflux oesophagitis

Ipreziv European Union - English - EMA (European Medicines Agency)

ipreziv

takeda pharma a/s - azilsartan medoxomil - hypertension - agents acting on the renin-angiotensin system - ipreziv is indicated for the treatment of essential hypertension in adults.

Rienso European Union - English - EMA (European Medicines Agency)

rienso

takeda pharma a/s - ferumoxytol - anemia; kidney failure, chronic - other antianemic preparations - rienso is indicated for the intravenous treatment of iron-deficiency anaemia in adult patients with chronic kidney disease (ckd).the diagnosis of iron deficiency must be based on appropriate laboratory tests (see section 4.2).

DEXLANSOPRAZOLE TAKEDA 30 Milligram Capsules Modified Release Ireland - English - HPRA (Health Products Regulatory Authority)

dexlansoprazole takeda 30 milligram capsules modified release

takeda pharma a/s - dexlansoprazole - capsules modified release - 30 milligram